PCR testing of pooled longitudinally collected cervical specimens of women to increase the efficiency of studying human papillomavirus infection

Cancer Epidemiology Biomarkers and Prevention

Volumn 14, Issue 1, 2005, Pages 256-260

  Castle, Philip E ^a   Schiffman, Mark ^a   Herrero, Rolando ^b   Hildesheim, Allan ^a   Rodriguez, Ana Cecilia ^b   Bratti, M Concepcion ^b   Wacholder, Sholom ^b   Kendal, Hortense ^c   Breheny, Anne M ^c   Prior, Andrew ^c   Pfeiffer, Ruth ^b   Burk, Robert D ^c  

^a NATIONAL CANCER INSTITUTE   (United States)

^b Proyecto Epidemiologico Guanacaste   (Costa Rica)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER GRADING; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; HUMAN; HUMAN CELL; LABORATORY DIAGNOSIS; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; PILOT STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; UTERINE CERVIX CYTOLOGY; UTERINE CERVIX TUMOR; VERRUCA VULGARIS; VIRUS GENE; WART VIRUS;

CERVICAL INTRAEPITHELIAL NEOPLASIA; FEMALE; HUMANS; LONGITUDINAL STUDIES; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PILOT PROJECTS; POLYMERASE CHAIN REACTION; REPRODUCIBILITY OF RESULTS; UTERINE CERVICAL NEOPLASMS;

EID: 19944433238     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Bosch FX, Manos MM, Munoz N, et al. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. J Natl Cancer Inst 1995;87:796-802.
2. Munoz N, Bosch FX, de Sanjose S, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003;348:518-27.
3. Walboomers JM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999;189:12-9.
4. Herrero R, Schiffman MH, Bratti C, et al. Design and methods of a population-based natural history study of cervical neoplasia in a rural province of Costa Rica: the Guanacaste Project. Rev Panam Salud Publica 1997;1:362-75.
5. Franco E, Villa L, Rohan T, Ferenczy A, Petzl-Erler M, Matlashewski G. Design and methods of the Ludwig-McGill longitudinal study of the natural history of human papillomavirus infection and cervical neoplasia in Brazil. Ludwig-McGill Study Group. Rev Panam Salud Publica 1999;6:223-33.
6. Kjaer SK, van den Brule AJ, Paull G, et al. Type specific persistence of high risk human papillomavirus (HPV) as indicator of high grade cervical squamous intraepithelial lesions in young women: population based prospective follow up study. BMJ 2002;325:572.
7. Koutsky L. Epidemiology of genital human papillomavirus infection. Am J Med 1997;102:3-8.
8. Bratti MC, Rodriguez AC, Schiffman M, et al. Description of a seven-year prospective study of human papillomavirus infection and cervical neoplasia among 10 000 women in Guanacaste, Costa Rica [Descripcion de un estudio prospectivo de siete anos sobre la infeccion por el virus del papiloma humano y el cancer cervicouterino en 10 000 mujeres de Guanacaste, Costa Rica]. Rev Panam Salud Publica 2004;15:75-89.
9. Herrero R, Hildesheim A, Bratti C, et al. Population-based study of human papillomavirus infection and cervical neoplasia in rural Costa Rica. J Natl Cancer Inst 2000;92:464-74.
10. Castle PE, Schiffman M, Gravitt PE, et al. Comparisons of HPV DNA detection by MY09/11 PCR methods. J Med Virol 2002;68:417-23.
11. Qu W, Jiang G, Cruz Y, et al. PCR detection of human papillomavirus: comparison between MY09/MY11 and GP5+/GP6+ primer systems. J Clin Microbiol 1997;35:1304-10.
12. Zweig MH, Campbell G. Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin Chem 1993;39:561-77.
13. Byrt T. How good is that agreement? Epidemiology 1996;7:561.
14. Breen G, Sham P, Li T, Shaw D, Collier DA, St Clair D. Accuracy and sensitivity of DNA pooling with microsatellite repeats using capillary electrophoresis. Mol Cell Probes 1999;13:359-65.
15. Collins HE, Li H, Inda SE, et al. A simple and accurate method for determination of microsatellite total allele content differences between DNA pools. Hum Genet 2000;106:218-26.
16. Pfeiffer RM, Rutter JL, Gail MH, Struewing J, Gastwirth JL. Efficiency of DNA pooling to estimate joint allele frequencies and measure linkage disequilibrium. Genet Epidemiol 2002;22:94-102.
17. Shaw SH, Carrasquillo MM, Kashuk C, Puffenberger EG, Chakravarti A. Allele frequency distributions in pooled DNA samples: applications to mapping complex disease genes. Genome Res 1998;8:111-23.
18. Daniel RW, Ahdieh L, Hayden D, Cu-Uvin S, Shah KV. Infra-laboratory reproducibility of human papillomavirus identification in cervical specimens by a polymerase chain reaction-based assay. J Clin Virol 2000;19:187-93.
19. Jacobs MV, Snijders PJ, van den Brule AJ, Heimerhorst Tf, Meijer CJ, Walboomers JM. A general primer GP5+/GP6(+)-mediated PCR-enzyme immunoassay method for rapid detection of 14 high-risk and 6 low-risk human papillomavirus genotypes in cervical scrapings. J Clin Microbiol 1997;35:791-5.
20. Van Doorn LJ, Quint W, Kleter B, et al. Genotyping of human papillomavirus in liquid cytology cervical specimens by the PGMY line blot assay and the SPF(10) line probe assay. J Clin Microbiol 2002;40:979-83.